Samantha Sartori, PhD
img_Samantha Sartori
ASSISTANT PROFESSOR | Medicine, Cardiology

Selected Publications

Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registry. Alessandro Spirito, Won Joon Koh, Samantha Sartori, Birgit Vogel, Yihan Feng, Usman Baber, Johny Nicolas, Clayton Snyder, Karim Kamaleldin, Brunna Pileggi, Vahid Rezvanizadeh, Joseph Sweeny, Samin K. Sharma, Annapoorna Kini, Stuart J. Pocock, George Dangas, Roxana Mehran. American Heart Journal

Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention. Davis Jones, Alessandro Spirito, Samantha Sartori, Kenneth F. Smith, Carlo Andrea Pivato, Mauro Chiarito, Davide Cao, Johny Nicolas, Frans Beerkens, Madison Edens, Brunna Pileggi, Ananya Sen, Zhongjie Zhang, Birgit Vogel, Joseph Sweeny, Usman Baber, George Dangas, Samin K. Sharma, Annapoorna Kini, Roxana Mehran. Journal of Cardiology

Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions. Guiomar Mendieta, Shamir Mehta, Usman Baber, Dominick J. Angiolillo, Carlo Briguori, David Cohen, Timothy Collier, George Dangas, Dariusz Dudek, Javier Escaned, Robert Gil, Birgit Vogel, Davide Cao, Alessandro Spirito, Kurt Huber, Adnan Kastrati, Upendra Kaul, Ran Kornowski, Mitchell W. Krucoff, Vijay Kunadian, David J. Moliterno, E. Magnus Ohman, Gennaro Sardella, Samantha Sartori, Samin Sharma, Richard Shlofmitz, P. Gabriel Steg, Ya Ling Han, Stuart Pocock, C. Michael Gibson, Roxana Mehran. Journal of the American College of Cardiology

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Sartori did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.